A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics (Q46308705)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics |
scientific article |
Statements
1 reference
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics (English)
1 reference
Werner Poewe
1 reference
Eduardo Tolosa
1 reference
Olivier Rascol
1 reference
Joseph Jankovic
1 reference
Robert A Hauser
1 reference
C Warren Olanow
1 reference
William Langston
1 reference
Eldad Melamed
1 reference
Eli Eyal
1 reference
1 November 2008
1 reference
1 reference
23
1 reference
15
1 reference
2194-2201
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference